Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SM Empreendimentos Farmacêuticos is the Brazilian subsidiary of the Fagron Group, a global leader in pharmaceutical compounding. The company operates as a central hub for Fagron's activities in Brazil, focusing on the wholesale distribution of pharmaceutical raw materials, medicines, and healthcare products. It manages several specialized divisions and brands, such as Florien Fitoativos, which focuses on phytotherapeutic ingredients. SM Empreendimentos Farmacêuticos is also active in the acquisition of strategic healthcare assets in the region, including companies like Vepakum and All Chemistry. Through its extensive logistics and manufacturing network, it supports hospitals, compounding pharmacies, and the broader pharmaceutical industry with high-quality inputs and customized therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SM Empreendimento Farmacêutica.